Newly Approved Lymphoma Drug Keeps Dogs Alive Longer

Lymphoma is one of the most common types of cancers to strike dogs, accounting for 10 to 20 percent of all cancer cases. It strikes in lymph nodes throughout the body and often spreads to various tissues. Now, a new chemotherapy treatment called Tanovea (rabacfosadine injection) has been fully approved by the Food and Drug […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Tufts Your Dog

Get the next year of Tufts Your Dog for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 44%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access


Please enter your comment!
Please enter your name here